| Literature DB >> 33029528 |
Khalid A Alahmari1, Paul Silvian1, Irshad Ahmad1, Ravi Shankar Reddy1, Jaya Shanker Tedla1, Venkata Nagaraj Kakaraparthi1, Kanagaraj Rengaramanujam1.
Abstract
Stretching is an important part of post ankle sprain rehabilitation, as well as an effective exercise for improving general ankle-joint performance. But the combination of stretching alongside low-frequency stimulation has not yet been extensively studied. Therefore, the purpose of the present randomized controlled trial was to compare the combined effects of low-frequency transcutaneous electrical nerve stimulation (TENS) with proprioceptive neuromuscular facilitation (PNF) on strength, balance, and proprioception among individuals with post ankle sprain. Sixty male subjects with lateral ankle sprain were selected and randomly allocated to three groups: group 1, group 2, and the control group (CG). Subjects in group 1 received the PNF stretching technique combined with TENS. TENS stimulation was provided using two electrodes placed 5 cm apart directly on the triceps sural muscle of the affected leg and a biphasic current with a symmetrical waveform at 50 Hz for 15 seconds, tuned for a 3-second ramp up time and a 30-second rest time with a 250-microsecond pulse duration was given with PNF stretching. Subjects in group 2 received the PNF stretching technique alone. Both group 1 and group 2 received these treatments for 4 weeks (4 days/week); follow-up assessments were administered in the third and fifth weeks. CG received no treatment; outcome measures alone were assessed. Outcome measures comprised pain, balance, flexibility, proprioception, range of motion, muscle strength, and functional limitation. A mixed-model ANOVA showed significant interaction (time and group) and the time effect for all the outcome measures (p ≤ 0.05). Group 1 (PNF-TENS) showed significant improvement for all the outcome variables compared to the other groups. The present study showed PNF stretching combined with TENS for the triceps sural muscle to trigger muscle contraction during the muscle contraction phase of the PNF stretch, compared against PNF stretching alone, produced significant improvements in ankle function for post ankle sprain subjects.Entities:
Mesh:
Year: 2020 PMID: 33029528 PMCID: PMC7532422 DOI: 10.1155/2020/9012930
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow chart enrolment for the study.
Figure 2Star Excursion Balance Test in anterior and posterolateral directions.
Figure 3Proprioception of the ankle in plantarflexion and dorsiflexion.
Figure 4Application of TENS electrode placements used to activate the triceps sural muscle and simultaneous PNF stretching.
Data (mean and standard deviation) of variables prior to intervention for each group.
| Variables | Group 1 | Group 2 | Control group (CG) |
|
|---|---|---|---|---|
| Age (years) | 25.8 ± 5.7 | 25.7 ± 5.6 | 25.9 ± 6.2 | 0.991 |
| Height (meters) | 1.6 ± 0.0 | 1.7 ± 0.0 | 1.7 ± 0.0 | 0.276 |
| Weight (kg) | 65.9 ± 14.1 | 72.6 ± 15.4 | 68.9 ± 13.6 | 0.346 |
| BMI | 23.0 ± 5.5 | 24.5 ± 4.5 | 23.1 ± 4.2 | 0.573 |
| Leg length (cm) | 83.4 ± 10 | 85.0 ± 5.4 | 86.3 ± 6.3 | 0.483 |
| SEBT anterior | 78.2 ± 2.5 | 68.5 ± 3.9 | 70.5 ± 5.9 | 0.01∗ |
| SEBT posterior | 92.4 ± 3.1 | 91.2 ± 4.6 | 90.7 ± 5.4 | 0.494 |
| SEBT medial | 95.7 ± 3.5 | 96.9 ± 3.7 | 96.6 ± 3.5 | 0.576 |
| SEBT lateral | 89.1 ± 5.9 | 92.9 ± 4.7 | 91.6 ± 5.5 | 0.090 |
| SEBT anterolateral | 74.9 ± 4.7 | 75.1 ± 3.9 | 75.8 ± 4.1 | 0.091 |
| SEBT anteromedial | 84.2 ± 5.8 | 83.1 ± 5.7 | 83.8 ± 5.7 | 0.843 |
| SEBT posterolateral | 95.1 ± 3.0 | 95.6 ± 2.9 | 94.9 ± 2.8 | 0.711 |
| SEBT posteromedial | 96.9 ± 2.6 | 96.8 ± 2.8 | 96.9 ± 3.3 | 0.998 |
| VAS | 2.7 ± 1.0 | 2.3 ± 1.0 | 2.2 ± 0.9 | 0.270 |
| KNEE to wall (cm) | 7.5 ± 1.8 | 6.7 ± 0.8 | 7.0 ± 0.8 | 0.180 |
| Dorsi proprioception | 2.1 ± 1.2 | 1.8 ± 1.0 | 1.9 ± 1.0 | 0.599 |
| Plantar proprioception | 2.5 ± 1.7 | 2.2 ± 1.9 | 2.4 ± 1.2 | 0.722 |
| Dorsi ROM | 15.9 ± 1.5 | 16.4 ± 1.8 | 16.7 ± 1.7 | 0.336 |
| Plantar ROM | 36.4 ± 3.9 | 38.5 ± 3.3 | 37.3 ± 4.0 | 0.224 |
| Dorsi MS (kg) | 11.1 ± 1.8 | 11.2 ± 0.8 | 11.1 ± 0.8 | 0.971 |
| Plantar MS (kg) | 13.2 ± 1.7 | 14.5 ± 0.9 | 14.1 ± 1.4 | 0.020 |
| FADI score | 94.3 ± 2.5 | 94.7 ± 3.5 | 95.3 ± 3.8 | 0.665 |
VAS: Visual Analogue Scale; BMI: Body Mass Index; ROM: range of motion; MS: muscle strength. ∗Significant (p ≤ 0.01).
Summary of statistical results of the mixed ANOVA and pooled means and standard deviations of all variable measures.
| Variables | Group 1 | Mean (standard deviation) | Mixed ANOVA ( | ||||
|---|---|---|---|---|---|---|---|
| Pre | 3rd week | 5th week | Interaction (group and time) effect | Group ( | Time ( | ||
| Pain VAS (cm) | TENS-PNF | 2.7 ± 1.0 | 0.5 ± 0.6 | 0.4 ± 0.5 | 0.608 (0.01)∗ | 0.192 (0.002)∗ | 0.674 (0.01)∗ |
| PNF | 2.3 ± 1.0 | 1.6 ± 0.8 | 1.6 ± 0.8 | ||||
| CG | 2.2 ± 0.9 | 2.0 ± 0.8 | 2.0 ± 0.8 | ||||
| Knee to wall (cm) | TENS-PNF | 7.5 ± 1.8 | 10.1 ± 1.2 | 10.2 ± 1.2 | 0.661 (0.01)∗ | 0.482 (0.01)∗ | 0.661 (0.01)∗ |
| PNF | 6.7 ± 0.8 | 7.5 ± 0.9 | 7.2 ± 1.0 | ||||
| CG | 7.0 ± 0.8 | 7.1 ± 0.8 | 7.1 ± 0.8 | ||||
| Dorsi proprioception | TENS-PNF | 2.1 ± 1.2 | 0.5 ± 0.5 | 0.4 ± 0.5 | 0.438 (0.01)∗ | 0.141 (0.01)∗ | 0.390 (0.01)∗ |
| PNF | 1.8 ± 1.0 | 1.5 ± 1.0 | 1.5 ± 1.0 | ||||
| CG | 1.9 ± 1.0 | 1.8 ± 1.0 | 1.8 ± 1.0 | ||||
| Plantar proprioception | EG 1 | 2.5 ± 1.7 | 0.2 ± 0.5 | 0.2 ± 0.5 | 0.520 (0.01)∗ | 0.244 (0.01)∗ | 0.439 (0.01)∗ |
| PNF | 2.2 ± 1.9 | 1.9 ± 1.0 | 1.9 ± 1.1 | ||||
| CG | 2.4 ± 1.2 | 2.4 ± 1.3 | 2.4 ± 1.2 | ||||
| Dorsiflexion ROM | TENS-PNF | 15.9 ± 1.5 | 18.6 ± 1.8 | 18.7 ± 1.8 | 0.655 (0.01)∗ | 0.064 (0.15)# | 0.622 (0.01)∗ |
| PNF | 16.4 ± 1.8 | 17.2 ± 1.9 | 18.7 ± 1.8 | ||||
| CG | 16.7 ± 1.7 | 16.8 ± 1.9 | 16.8 ± 1.8 | ||||
| Plantarflexion ROM | TENS-PNF | 36.4 ± 3.9 | 43.5 ± 3.7 | 43.6 ± 3.9 | 0.729 (0.01)∗ | 0.148 (0.01)∗ | 0.693 (0.01)∗ |
| PNF | 38.5 ± 3.3 | 39.9 ± 3.4 | 39.3 ± 3.0 | ||||
| CG | 37.3 ± 4.0 | 37.5 ± 4.1 | 37.5 ± 4.3 | ||||
| Dorsiflexion MS | TENS-PNF | 11.1 ± 1.8 | 13.9 ± 1.7 | 13.9 ± 1.7 | 0.741 (0.01)∗ | 0.298 (0.01)∗ | 0.736 (0.01)∗ |
| PNF | 11.2 ± 0.8 | 11.7 ± 0.7 | 11.6 ± 0.6 | ||||
| CG | 11.1 ± 0.8 | 11.3 ± 0.8 | 11.3 ± 0.8 | ||||
| Plantarflexion MS | TENS-PNF | 13.2 ± 1.7 | 17.1 ± 1.7 | 17.1 ± 1.7 | 0.594 (0.01)∗ | 0.218 (0.01)∗ | 0.541 (0.01)∗ |
| PNF | 14.5 ± 0.9 | 15.1 ± 0.9 | 14.9 ± 1.0 | ||||
| CG | 14.1 ± 1.4 | 14.3 ± 1.5 | 14.2 ± 1.5 | ||||
| FADI score | TENS-PNF | 94.3 ± 2.5 | 98.4 ± 1.9 | 98.6 ± 1.7 | 0.678 (0.01)∗ | 0.078 (0.098)# | 0.651 (0.01)∗ |
| PNF | 4.7 ± 3.5 | 5.3 ± 3.4 | 95.3 ± 3.4 | ||||
| CG | 5.3 ± 3.8 | 5.5 ± 3.7 | 95.5 ± 3.7 | ||||
VAS: Visual Analogue Scale; ROM: range of motion; MS: muscle strength; FADI: the Foot and Ankle Disability Index score. ∗Significant effect (p ≤ 0.05). #Nonsignificant.
Summary of statistical results of the mixed ANOVA and means and standard deviations of balance.
| Balance | Group 1 | Mean (standard deviation) | Mixed ANOVA ( | ||||
|---|---|---|---|---|---|---|---|
| Pre | 3rd week | 5th week | Interaction (group and time) effect | Group ( | Time ( | ||
| SEBT anterior | TENS-PNF | 78.2 ± 2.5 | 81.9 ± 3.1 | 82.5 ± 2.6 | 0.613 (0.01)∗ | 0.593 (0.01)∗ | 0.670 (0.01)∗ |
| PNF | 68.5 ± 3.9 | 70.2 ± 4.1 | 69.4 ± 4.2 | ||||
| CG | 70.5 ± 5.9 | 70.7 ± 7.0 | 70.8 ± 7.3 | ||||
| SEBT posterior | TENS-PNF | 92.4 ± 3.1 | 96.1 ± 3.1 | 96.3 ± 3.1 | 0.655 (0.01)∗ | 0.136 (0.01)∗ | 0.710 (0.01)∗ |
| PNF | 91.2 ± 4.6 | 92.4 ± 4.5 | 92.3 ± 4.7 | ||||
| CG | 90.7 ± 5.4 | 90.9 ± 5.3 | 91.0 ± 5.2 | ||||
| SEBT medial | TENS-PNF | 95.7 ± 3.5 | 99.8 ± 4.1 | 100.1 ± 4.1 | 0.727 (0.01)∗ | 0.043 (0.28)# | 0.758 (0.01)∗ |
| PNF | 96.9 ± 3.7 | 98.3 ± 3.5 | 98.1 ± 3.7 | ||||
| CG | 96.6 ± 3.5 | 96.8 ± 3.3 | 96.7 ± 3.4 | ||||
| SEBT lateral | TENS-PNF | 89.1 ± 5.9 | 92.1 ± 5.9 | 92.2 ± 5.7 | 0.607 (0.01)∗ | 0.033 (0.38)# | 0.624 (0.01)∗ |
| PNF | 92.9 ± 4.7 | 93.9 ± 4.2 | 93.4 ± 4.1 | ||||
| CG | 91.6 ± 5.5 | 91.8 ± 5.4 | 91.8 ± 5.1 | ||||
| SEBT anterolateral | TENS-PNF | 74.9 ± 4.7 | 77.0 ± 4.6 | 77.3 ± 4.7 | 0.653 (0.01)∗ | 0.001 (0.96)# | 0.671 (0.01)∗ |
| PNF | 75.1 ± 3.9 | 76.4 ± 3.8 | 75.6 ± 4.0 | ||||
| CG | 75.8 ± 4.1 | 76.1 ± 4.0 | 76.1 ± 4.0 | ||||
| SEBT anteromedial | TENS-PNF | 84.2 ± 5.8 | 88.1 ± 5.9 | 88.7 ± 5.8 | 0.562 (0.01)∗ | 0.062 (0.15)# | 0.602 (0.01)∗ |
| PNF | 83.1 ± 5.7 | 84.3 ± 5.7 | 84.2 ± 5.4 | ||||
| CG | 83.8 ± 5.7 | 84.1 ± 5.8 | 84.1 ± 5.8 | ||||
| SEBT posterolateral | TENS-PNF | 95.1 ± 3.0 | 98.6 ± 2.4 | 98.9 ± 2.4 | 0.678 (0.01)∗ | 0.118 (0.02)∗ | 0.703 (0.01)∗ |
| PNF | 95.6 ± 2.9 | 96.7 ± 3.2 | 96.3 ± 3.4 | ||||
| CG | 94.9 ± 2.8 | 95.1 ± 2.9 | 95.1 ± 2.9 | ||||
| SEBT posteromedial | TENS-PNF | 96.9 ± 2.6 | 102.1 ± 4.0 | 102.3 ± 4.0 | 0.633 (0.01)∗ | 0.181 (0.01)∗ | 0.638 (0.01)∗ |
| PNF | 96.8 ± 2.8 | 98.3 ± 3.2 | 97.7 ± 3.3 | ||||
| CG | 96.9 ± 3.3 | 97.2 ± 3.0 | 97.1 ± 3.0 | ||||
SEBT: Star Excursion Balance Test. ∗Significant effect (p ≤ 0.05). #Nonsignificant.
Figure 5Mean values of the group and time interaction effect of the outcome variables measured at the pre, 3rd week, and 5th week for Star Excursion Balance Test (SEBT). A: anterior; P: posterior; M: medial; L: lateral; AM: anteromedial; AL: anterolateral; PM: posteromedial; PL: posterolateral.
Figure 6Mean values of the group and time interaction effect of the outcome variables measured at pre, 3rd week, and 5th week for pain, flexibility, proprioception, range of motion, muscle strength, and functional limitation. VAS: Visual Analogue Scale; ROM: range of motion.